Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

PriceSmart's (PSMT) May Comps Down On Currency Headwinds

Published 06/09/2019, 10:01 PM
Updated 07/09/2023, 06:31 AM

PriceSmart, Inc. (NASDAQ:PSMT) comparable warehouse sales (comps) for the five-week period (ended Jun 2, 2019) for 40 warehouse clubs fell 0.9%, following a 0.5% decline in April. Comps for March, February and January dropped 1%, 1.9% and 1.4%, respectively. We note that foreign currency exchange rate fluctuations adversely impacted comps by 3.9%.

For the 39-week period (ended Jun 2, 2019), comps declined 1.3%. Foreign currency exchange rate fluctuations negatively impacted comps by 3.3%.

Nevertheless, net merchandise sales increased 0.8% to $251 million from $248.7 million in the year-ago period. However, the metric was adversely impacted by currency rate fluctuations to the tune of $9.6 million or 3.8%. In the preceding month, the company posted net merchandise sales growth of 0.9%, while for March the metric inched up 0.1%. In February, it remained flat and improved 0.3% in January.

Net merchandise sales advanced 0.4% to $2,322.6 million for the nine months (ended May 31, 2019) from $2,312.2 million in the same period last year. Foreign currency exchange rate fluctuations hurt net merchandise sales by $77.1 million or 3.3%.

We note that comparable net merchandise sales in the second quarter of fiscal 2019 dipped 0.9%. Adverse currency fluctuations negatively impacted comparable net merchandise sales by 3.7%.

Brighter Side of the Story

Despite weak comps performance, this Zacks Rank #2 (Buy) company’s total sales grew 1.8% to $839.6 million on a year-over-year basis in the second quarter of fiscal 2019. Total revenues included a $9.9 million contribution from the Aeropost acquisition. Net merchandise sales rose 0.5%. PriceSmart’s strategy to sell limited products at lower prices has helped it generate member loyalty and higher sales.

Interested in the Retail Space? Check These

Children’s Place (NASDAQ:PLCE) , with a long-term earnings per share growth rate of 8%, sports a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

L Brands (NYSE:LB) , with a long-term earnings per share growth rate of 11%, carries a Zacks Rank #2.

Kering (PA:PRTP) SA (OTC:PPRUY) , with a long-term earnings per share growth rate of 10%, carries a Zacks Rank #2.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +98%, +119% and +164% in as little as 1 month. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>


Kering SA (PPRUY): Free Stock Analysis Report

L Brands, Inc. (LB): Free Stock Analysis Report

Children's Place, Inc. (The) (PLCE): Free Stock Analysis Report

PriceSmart, Inc. (PSMT): Free Stock Analysis Report

Original post

Zacks Investment Research

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.